Jordan E Lake

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial
    Jordan E Lake
    Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e58135. 2013
  2. pmc A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy
    Jordan E Lake
    Department of Medicine, University of California, Los Angeles, Los Angeles, California 90035, USA
    AIDS Patient Care STDS 26:532-40. 2012
  3. pmc Vitamin D in HIV-Infected Patients
    Jordan E Lake
    Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, USA
    Curr HIV/AIDS Rep 8:133-41. 2011
  4. doi Metabolic disease in HIV infection
    Jordan E Lake
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Lancet Infect Dis 13:964-75. 2013
  5. pmc A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men
    Raphael J Landovitz
    UCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California, Los Angeles, USA
    AIDS Patient Care STDS 26:320-8. 2012
  6. pmc Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study
    Jordan E Lake
    Division of Infectious Diseases, CARE Center, UCLA, Los Angeles, CA, USA
    AIDS Care 23:929-38. 2011
  7. pmc Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience
    Jordan E Lake
    Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, USA
    HIV AIDS (Auckl) 3:61-8. 2011

Detail Information

Publications7

  1. pmc A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial
    Jordan E Lake
    Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e58135. 2013
    ..Telmisartan, an angiotensin receptor blocker and partial PPAR-γ agonist, has been shown to decrease visceral fat and improve metabolic and inflammatory parameters in HIV-uninfected subjects...
  2. pmc A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy
    Jordan E Lake
    Department of Medicine, University of California, Los Angeles, Los Angeles, California 90035, USA
    AIDS Patient Care STDS 26:532-40. 2012
    ..Additional insights into AT and metabolic changes in women on RAL will be provided by 48-week follow-up of the immediate-switch arm...
  3. pmc Vitamin D in HIV-Infected Patients
    Jordan E Lake
    Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, USA
    Curr HIV/AIDS Rep 8:133-41. 2011
    ..This paper reviews data published on HIV infection and vitamin D health in adults over the last year...
  4. doi Metabolic disease in HIV infection
    Jordan E Lake
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Lancet Infect Dis 13:964-75. 2013
    ....
  5. pmc A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men
    Raphael J Landovitz
    UCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine, University of California, Los Angeles, USA
    AIDS Patient Care STDS 26:320-8. 2012
    ..Findings demonstrate that PEP, when combined with CM, is safe, feasible, and acceptable as an HIV prevention strategy in methamphetamine-using MSM...
  6. pmc Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study
    Jordan E Lake
    Division of Infectious Diseases, CARE Center, UCLA, Los Angeles, CA, USA
    AIDS Care 23:929-38. 2011
    ..Peripheral lipoatrophy (as measured by leg SAT) is associated with striking increased CVD risk in HIV-infected patients even after controlling for VAT, whereas low leg SAT is associated with low CVD risk in controls...
  7. pmc Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience
    Jordan E Lake
    Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, USA
    HIV AIDS (Auckl) 3:61-8. 2011
    ..This analysis describes the characteristics of women in the cohort who participated in HIV clinical trials between 1999 and 2008...